Photocure ASA (PHO):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C2718)
◆英語タイトル:Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2718
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:47
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Photocure ASA (PHO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Photocure ASA (Photocure) is a specialty pharmaceutical company with focus on cancer and dermatology. It develops and markets pharmaceuticals and medical devices for the diagnosis and treatment of various types of cancer and precancerous conditions based on its photodynamic technology. The company’s flagship product Hexvix is an optical imaging agent used for the detection of bladder cancer. The company offers this product under the name Cysview in the US for the use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder. Photocure’s major product candidates include Cevira (in Phase II studies) for the treatment of HPV infection and precancerous lesions of the cervix and Visonac (in Phase II studies) for the treatment of moderate to severe acne. The company sells its product in Sweden, Norway, Germany, France and the US, Canada and Australia/New Zealand. Photocure is headquartered in Oslo, Norway.

Photocure ASA Key Recent Developments

Jun 26,2018: Photocure Announces Resignation Of Kjetil Hestdal As CEO
May 23,2018: Photocure: Results for the first quarter of 2018
Feb 27,2018: Photocure: Results for the fourth quarter of 2017
Nov 07,2017: Photocure: Results for the third quarter of 2017
Aug 23,2017: Photocure: Results for second quarter and first half year of 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Photocure ASA – Key Facts 6
Photocure ASA – Key Employees 7
Photocure ASA – Key Employee Biographies 8
Photocure ASA – Major Products and Services 9
Photocure ASA – History 10
Photocure ASA – Company Statement 12
Photocure ASA – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Photocure ASA – Business Description 15
Business Segment: Commercial Franchise 15
Overview 15
Performance 15
Business Segment: Development Portfolio 15
Overview 15
Geographical Segment: Nordic countries 16
Performance 16
Geographical Segment: Partner countries Europe 16
Performance 16
Geographical Segment: Partner countries Rest of World 16
Performance 16
Geographical Segment: The US 16
Performance 16
Photocure ASA – Corporate Strategy 17
Photocure ASA – SWOT Analysis 18
SWOT Analysis – Overview 18
Photocure ASA – Strengths 18
Photocure ASA – Weaknesses 19
Photocure ASA – Opportunities 20
Photocure ASA – Threats 21
Photocure ASA – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Photocure ASA, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
May 23, 2018: Photocure: Results for the first quarter of 2018 33
Feb 27, 2018: Photocure: Results for the fourth quarter of 2017 34
Nov 07, 2017: Photocure: Results for the third quarter of 2017 35
Aug 23, 2017: Photocure: Results for second quarter and first half year of 2017 36
May 23, 2017: Photocure: Results for the first quarter of 2017 37
May 16, 2017: Photocure: Presentation of results from the Blue Light Flexible Cystoscopy with Hexvix/Cysview phase 3 study 38
May 12, 2017: Phase 3 study investigating Blue Light Flexible Cystoscopy with Cysview in surveillance setting meets primary endpoint 39
May 05, 2017: Jeremy Bahr Appointed Chief Business Officer 40
Apr 28, 2017: Photocure Appoints Three New Members to Its Board of Directors 41
Apr 05, 2017: Photocure Provides Strategic Update 42
Section 6 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Photocure ASA, Key Facts 6
Photocure ASA, Key Employees 7
Photocure ASA, Key Employee Biographies 8
Photocure ASA, Major Products and Services 9
Photocure ASA, History 10
Photocure ASA, Subsidiaries 13
Photocure ASA, Key Competitors 22
Photocure ASA, Ratios based on current share price 23
Photocure ASA, Annual Ratios 24
Photocure ASA, Annual Ratios (Cont...1) 25
Photocure ASA, Annual Ratios (Cont...2) 26
Photocure ASA, Interim Ratios 28
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Photocure ASA, Recent Deals Summary 32
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46

List of Figures
Photocure ASA, Performance Chart (2013 - 2017) 27
Photocure ASA, Ratio Charts 29
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Photocure ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Photocure ASA (PHO):企業の財務・戦略的SWOT分析(Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆